Our work identifies KRAP as a promising new target for intervention in obesity and obesity-related diseases and establishes the KRAP−/− mouse as a novel model of metabolism-related diseases. Here, ITPRID2 is linked to obesity due to melanocortin 4 receptor deficiency.